Sarah B. Noonberg, M.D., Ph.D.

Sarah B. Noonberg, M.D., Ph.D.

DirectoratNeurogene· In proxies 2023–2025

Sarah B. Noonberg, M.D., Ph.D. sits on 3 public boards.

Boards1

  • NeurogeneDirector · 6 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. NeurogenePublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +246%
  2. Protagonist TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Marinus Pharmaceuticals, Inc.Public company · 1 yr
    • Director2023 – 2024 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?